Skip to main content
. 2020 Nov 6;12(11):3408. doi: 10.3390/nu12113408

Table 1.

Summary of the study schedule for enrolment, intervention and assessment.

Assessments Screening & Enrollment Visit
1
Visit
2
Visit
3
Visit
4
Day in study 1 28 42 84
Week in study −2 1–4 5,6 7–10 11,12
General information form
Informed consent
Medical history
Weight
Non-nutritive sweetener supplementation 1
Blood draw 2 (1.5 mL) session
Stool sample collection
Laboratory measurements in plasma: glucose, insulin, glucagon,
GLP-1, leptin
Laboratory measurements in stool:
fecal microbiome, fecal short-chain fatty acids (SCFA)
Oral glucose tolerance test (OGTT) 3
Fasting blood glucose (FBG) test 4
Visual analogue scales (taste panel) 5
Diet history questionnaire
Food diary 6
Adverse event log

1 This will be either aspartame or sucralose; visits to collect the supply will vary. 2 There will be five blood draws after the visits, and they will be conducted at the Richardson Centre for Functional Foods and Nutraceuticals (RCFFN). 3 OGTT will involve drinking a sweet liquid containing 75 g of glucose. 4 FBG will be conducted after a 10–12 h fast. 5 This test is to measure the participants’ tolerance to the sweetener mixed into beverages. 6 Food diaries documenting 2 weekdays and 1 weekend day.